BIND THERAPEUTICS INC Instrumento Inactivo
Empresa BIND Therapeutics Inc Nasdaq
Acciones
US05548N1072
Biotecnología e investigación médica
Directores
| Directores | Puesto | Edad | Desde |
|---|---|---|---|
Stephen Zale
CTO | Chief Tech/Sci/R&D Officer | 68 | 01/11/06 |
Tom Baker
IRC | Investor Relations Contact | - | - |
Neil Bander
PRN | Corporate Officer/Principal | - | - |
| Corporate Officer/Principal | - | 24/07/16 | |
James L. Wright
PRN | Corporate Officer/Principal | 76 | 01/01/07 |
Administradores
| Administradores | Puesto | Edad | Desde |
|---|---|---|---|
| Corporate Officer/Principal | - | 24/07/16 |
Clase de acciones
| Vote | Quantity | Flotante | Autocontrol | Total Float | |
|---|---|---|---|---|---|
| Acción A | 1 | 20 886 802 | 17 860 424 ( 85,51 %) | 0 | 85,51 % |
Información de la empresa
DNIB Unwind, Inc.
333 South Grand Avenue Suite 4100
90071, Los Angeles
+617-491-3400
http://bindtherapeutics.com
Sector
| Varia. 1 de ene. | Capi. | |
|---|---|---|
| -3,46 % | 102 mil M | |
| +1,41 % | 96,09 mil M | |
| +2,13 % | 22,28 mil M | |
| -15,84 % | 21,4 mil M | |
| -9,28 % | 18,14 mil M | |
| -39,98 % | 17,02 mil M | |
| -14,65 % | 16,09 mil M | |
| +4,39 % | 13,83 mil M | |
| +31,35 % | 11,97 mil M |
